Provectus Biopharmaceuticals, Inc. (PVCT) stock
PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05+0.00 (+0.39%)
Close on Oct 19, 2026Market cap $20.55MP/E –Yield –
Provectus Biopharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Provectus Biopharmaceuticals's price to sales ratio was 71.3× on Apr 30, 2026, against 63.3× a year earlier. Over the last 3 years it ranged from 39.6× to 148.9×, with a median of 67.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 71.3× | +4.2 |
| 2025 | Dec 31, 2025 | 67.0× | −2.7 |
| 2024 | Dec 31, 2024 | 69.7× | +2.8 |
| 2023 | Dec 29, 2023 | 67.0× | – |
See a number that looks wrong?